Dr. Reddy’s Laboratories has announced the inauguration of a state-of-the-art biologics facility in Hyderabad, dedicated to process and analytical development, as well as small-scale manufacturing of antibodies and recombinant proteins for preclinical and early phase clinical trials. The 70,000 sq ft facility, managed by Dr. Reddy’s CRDMO arm Aurigene Pharmaceutical Services Limited, is located in the renowned Genome Valley, Hyderabad.
Currently, the process and analytical development laboratories are operational, with the manufacturing capacity slated to be commissioned later in 2024. This new facility enhances Aurigene’s existing capabilities, primarily focusing on recombinant proteins, monoclonal antibodies (mAbs), bi- and multi-specifics, immune-fusion molecules, antibody-drug conjugates, and other complex proteins.
The establishment of this facility allows Aurigene to provide comprehensive end-to-end services, ranging from discovery through to large-scale commercial manufacturing, across its three campuses. The facility aims to deliver robust, compliant, and cost-effective cell lines, process development solutions, and supporting analytical methods to accelerate the clinical development of biologics.
This strategic initiative is part of Aurigene’s broader efforts to expand in the small molecule and biologics sectors, including AI/ML-led drug discovery and a recent collaboration with Vipergen. The new facility is poised to significantly enhance Aurigene’s ability to serve its global clientele and support the development of innovative medicines.
Aurigene CEO Akhil Ravi highlighted the importance of the new capacity and capabilities in enhancing global customer service and supporting the development of cutting-edge medicines. Dr. Roger Lias, Global Commercial Head of Biologics at Aurigene, emphasized that the facility strengthens Aurigene’s ability to support customers from discovery through to large-scale commercial manufacturing, ensuring a seamless transition from early-stage development to market-ready products.
